1. Recombinant Capital. Year-end '98 financing numbers: A Tale of Two Biotechs. Signals Magazine, (
http://www.signalsmagazine.com
) February 7, 1999.
2. Ernst & Young LLP. Convergence: Ernst and Young's Biotechnology Industry Report, Millennium Edition (Ernst & Young, New York, 2000).
3. Solt, M.E. SWORD financing of innovation in the biotechnology industry. Financial Management 22, 173–187 (1993).
4. Edwards, M. et al. Value creation and sharing among universities, biotechnology and pharma. Nat. Biotechnol. 21, 618–624 (2003).
5. Financial Accounting Standards Board. Exposure Draft, Proposed Interpretation: Consolidation of Certain Special Purpose Entities, an interpretation of ARB NO. 51, File ref. no. 1082-200 (FASB, Norwalk, CT, June 28, 2002).